Tetra Radar · FDA Approvals · Decision date

Belite Bio Inc: FDA decision date

Belite Bio Inc (BLTE) · 12 February 2027

Food and Drug Administration (FDA) in August 2026 with Prescription Drug User Fee Act (PDUFA) target action date of February 12, 2027. ·.

Source: 6-K of 12 November 2026

The decision is pending.

Belite Bio Inc on Tetra Radar

A PDUFA date is the date by which the FDA has said it will decide on an application. Dates can move, and a decision is not an approval. Tetra Radar observes public information for research purposes. It does not provide investment advice.

Get the Dispatch free.